Expert panel’s meet on COVID-19 vaccine approval begins
New Delhi: Key meeting of drug regulator's expert panel is currently underway to take a call on the emergency use ...
Read moreNew Delhi: Key meeting of drug regulator's expert panel is currently underway to take a call on the emergency use ...
Read moreNew Delhi: Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 ...
Read moreNew Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in ...
Read moreNew Delhi: Vaccine major Serum Institute of India Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford University is ...
Read moreNew Delhi: Adar Poonawalla, CEO and Owner of Serum Institute of India (SII) is putting $250 million of his family's ...
Read moreNew Delhi: The Drugs Controller General of India (DCGI) has given nod to Serum Institute of India (SII) for conducting ...
Read morePune: "More than enough" doses of the COVID-19 vaccine developed by Oxford University and AstraZeneca will be reserved for the ...
Read more